Kenneth J Winters

Kenneth J Winters

Auto-generated profile, based on publicly available information

Kenneth J Winters

11Eli Lilly and Company, Indianapolis, IN, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2013 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
TWTed Wun
Ted Wun
DSDenis Soulieres
Denis Soulieres
AFAndrew L Frelinger
Andrew L Frelinger
LKLakshmanan Krishnamurti
Lakshmanan Krishnamurti
ENEnrico M Novelli
Enrico M Novelli
KWKenneth J Winters
Kenneth J Winters
Platelet activation has been implicated in the pathogenesis of sickle cell disease (SCD) suggesting antiplatelet agents may be therapeutic. To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we conducted a double-blind, randomized, placebo-controlled study.